IP Library Granted Patent US 10,682,532
Granted Patent B2
US 10,682,532 · App. 15/964,138 · Granted Jun 16, 2020

Low water stannous fluoride plus zinc citrate dentifrice with improved stability, rheology, and efficacy

Inventors: Steven Fisher (Middlesex, NJ); Linh Fruge (Hillsborough, NJ); Michael Prencipe (West Windsor, NJ)
Assignee: Colgate-Palmolive Company
A61Q11/00A61K8/20A61K8/24A61K8/365A61K2800/31
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,682,532
App. No.
15/964,138
Granted
Jun 16, 2020
Kind
B2
Abstract

A dentifrice composition having a low water phase comprising effective amounts of polyphosphate and ionic active ingredients.

Claims (29)

1. A dentifrice composition comprising in a single phase:

an orally acceptable vehicle;

a source of fluoride ions;

a source of stannous ions, wherein the source of stannous ions comprises stannous fluoride;

a source of zinc ions, wherein the zinc ion source is zinc citrate or zinc lactate; and

at least one polyphosphate salt selected from the group consisting of inorganic polyphosphate salts which have equal to or less than three phosphorous atoms;

wherein the dentifrice composition has a total water content of less than about 10% based on the weight of the composition; and

the vehicle comprises a thickening agent comprising, in combination, a cross-linked polyvinylpyrrolidone present in an amount of about 0.75 to 1.25 wt % of the composition and xanthan gum present in an amount from about 0.2 to 0.3 wt % of the composition.

2. The composition of claim 1 , wherein the at least one polyphosphate is selected from the group consisting of an alkali metal salt of a pyrophosphate, an alkali metal salt of a tripolyphosphate, and mixtures thereof.

3. The composition of claim 2 , wherein the at least one polyphosphate is selected from the group consisting of tetrasodium pyrophosphate, sodium tripolyphosphate, and mixtures thereof.

4. The composition of claim 3 , wherein the at least one polyphosphate comprises a mixture of tetrasodium pyrophosphate and sodium tripolyphosphate.

5. The composition of claim 4 , wherein the mixture of tetrasodium pyrophosphate and sodium tripolyphosphate comprises tetrasodium pyrophosphate and sodium tripolyphosphate in about a 2:3 weight ratio.

6. The composition of claim 1 , wherein the at least one polyphosphate comprises from 1 to 10 wt % of the composition.

7. The composition of claim 6 , wherein the at least one polyphosphate comprises from 3 to 7 wt % of the composition.

8. The composition of claim 1 , wherein the source of zinc ions comprises zinc citrate.

9. The composition of claim 1 , further comprising an aqueous buffer system for the source of stannous ions.

10. The composition of claim 9 , wherein the buffer system is adapted to chelate the stannous ions in the composition.

11. The composition of claim 10 , wherein the buffer system comprises at least one of an organic acid or an alkali metal salt thereof.

12. The composition of claim 11 , wherein the organic acid is citric acid.

13. The composition of claim 11 , wherein the buffer system comprises a mixture of citric acid and trisodium citrate.

14. The composition of claim 11 , wherein the buffer system comprises from 0.1 to 10 wt % of the composition.

15. The composition of claim 11 , wherein the buffer system is present, by weight, in an amount which is greater than the amount, by weight, of the source of stannous ions.

16. The composition of claim 1 , wherein the dentifrice composition has a total water content of less than about 6% based on the weight of the composition.

17. The composition of claim 1 , wherein the cross-linked polyvinylpyrrolidone comprises a homopolymer of N-vinyl-2-pyrrolidone.

18. The composition of claim 1 , wherein the cross-linked polyvinylpyrrolidone comprises from 0.75 to 1.25 wt % of the composition.

19. The composition of claim 1 , further comprising at least one humectant selected from the group consisting of glycerin, polyethylene glycol, propylene glycol, and mixtures thereof.

20. A method for the treatment and prevention of bacterial plaque accumulation or prevention of tooth erosion, comprising administering to the oral cavity the dentifrice composition according to claim 1 .

21. The oral care composition of claim 1 , wherein the source of zinc ions is zinc lactate.

22. The oral care composition of claim 8 , wherein the amount of zinc citrate is about 2% by wt. of the composition.

Continuity (2)
Continuation 13503801
Related Publication 20180243588A1 · Aug 30, 2018